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Use of regulated (e.g. alcohol and nicotine) and unregulated (e.g. 
heroin, cannabis and cocaine) substances is common and a routine 
part of individual and collective social interaction. About 6% of 
the world’s population use an unregulated substance,[1] and a third 
of Africa’s population report regular alcohol use.[2] Whether these 
substances are intended to aid relaxation, increase energy and 
motivation or relieve boredom,[3-6] certain patterns of use contribute 
to negative health and social outcomes and are linked to poor health, 
crime, family disruption, economic instability and conflict.[7]
Unregulated substances, usually bought off the street, hold 
additional dangers independent of the substance. Contamination 
with other substances and unknown concentration increase the risk 
of poisoning and overdose.[1] Substances can be consumed through 
various routes, not limited to ingestion, smoking and injecting. 
The relative risks of overdose and the transmission of blood-borne 
infections are higher through injecting than other routes. Lack 
of sterile injecting equipment and subsequent sharing of needles 
increases the risk of HIV infection 22-fold,[8] and hepatitis C is at 
least 10 times more infectious per injecting event than HIV.[9] This 
said, multi-criteria decisional analyses on the relative harms of 
regulated and unregulated substances in the UK[10] and Europe[11] 
suggest that alcohol creates the most harms to individuals and society, 
trumping all other substances, including heroin. In South Africa (SA), 
alcohol is the leading risk factor for disability-adjusted life-years and 
mortality,[10,12] and there are global and event-level associations 
between alcohol consumption and poor adherence to antiretroviral 
therapy.[13,14] Further, more than one-third of HIV-positive patients 
engage in heavy episodic drinking.[15] In multi-criteria decision 
analysis, tobacco ranks between cocaine and amphetamines in terms 
of potential harms.[10] The negative effects of smoking tobacco are 
well documented, and longstanding tobacco use diminishes overall 
health, increases health service utilisation and cost, and reduces 
individual functionality and productivity.[16] The use of more than 
one substance is common, and has been reported by 40 - 56% of 
patients accessing specialised substance use disorder treatment 
centres in SA.[17] Polysubstance use (the use of several substances 
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Results. Most patients were South African (88%) and black African (79%), over half were female (57%), and they were relatively young 
(median age 38 years). Most (82%) lived in formal housing. Over half (56%) had completed high school, and 33% were formally employed. 
Bivariate analysis found substance use-related admission to be higher where scores for tobacco and unregulated substance use were 
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use to be positively associated with male sex (adjusted odds ratio (aOR) 7.9, 95% confidence interval (CI) 2.9 - 21.5), age <38 years (aOR 3.3, 
95% CI 1.2 - 8.9), moderate- to high-risk alcohol use (aOR 3.1, 95% CI 1.1 - 8.4; p=0.027) and being admitted to Tshwane District Hospital 
(aOR 3.6, 95% CI 1.1 - 12.2). It was negatively associated with employment (aOR 0.2, 95% CI 0.1 - 0.6).
Conclusions. Moderate- to high-risk substance use is an undetected, unattended comorbidity in the hospital setting in Tshwane, 
particularly among young, single, unemployed men. Clinicians should identify and respond to this need. Further research is required on 
the implementation of in-hospital substance use screening and treatment interventions.
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within a specified period of time) increases potential health risks of 
individual substances and the burden on the health system.[18]
Objectives
Given limited systematic information but widespread tacit knowledge 
of alcohol and other substance use in the SA general population,[19] 
there is a need to find out about their use among people who have 
been hospitalised to inform screening and interventions in the 
inpatient setting. This study describes the prevalence of regulated 
and unregulated substance use, substance use treatment seeking and 
interest in harm reduction among patients admitted to four hospitals 
in the City of Tshwane. The study also sought to characterise 
individuals at risk to inform screening and treatment interventions 
in the hospital setting. The study focused on inpatients for logistical 
reasons and interest around substance use and clinical care in 
the inpatient setting. It forms part of the Community Orientated 
Substance Use Programme (COSUP) being implemented by the 
University of Pretoria’s Department of Family Medicine.
Methods
Study setting
The study was conducted in four hospitals. These hospitals form the 
Tshwane Steve Biko Academic Hospital Cluster that services five of 
the seven subdistricts in the Tshwane Metropolitan Municipality 
and is part of the University of Pretoria’s academic platform. The 
hospitals predominantly serve the majority of the middle to low 
socioeconomic segments of the population. Steve Biko Academic 
Hospital is a tertiary hospital with 832 beds located in central 
Pretoria. Patients are referred from surrounding health facilities or 
admitted through the emergency/casualty unit. Kalafong Hospital is a 
tertiary hospital with 857 beds servicing the western areas of the city. 
Tshwane District Hospital is a 200-bed district hospital that drains 
the city’s central business district and surrounds. Mamelodi Hospital, 
with ~325 beds, is a secondary hospital servicing Mamelodi township 
(an urban black African settlement created under the apartheid 
system) and surrounds.
Study design
This was a cross-sectional descriptive study.
Study population and sampling
The study population comprised patients aged ≥16 years admitted 
to any one of the four hospitals. Patients aged <16 years, those in the 
intensive and high-care units of the hospitals, those who were too ill 
to answer the questions and those who declined to take part were 
excluded.
Sample size and selection
The sample size was calculated using G*Power, March 2014 version 
(University of Dusseldorf). The sample size was based on the 
assumption that the proportion of people admitted to hospital with 
moderate- to high-risk substance use was 10%. A sample of 400 
enabled this proportion to be estimated with a precision of ±3% (95% 
confidence interval (CI)). A total of 401 participants were recruited, 
with sample sizes proportional to total hospital inpatient capacity 
(425 patients were approached and 24 declined, giving a response 
rate of 94%). Systematic sampling was used to select participants. 
Study team members numbered beds in each ward, assigning each 
bed a number between 1 and 5. Beds were numbered sequentially 
in a clockwise manner with the first bed being bed 1. In each ward, 
a random bed was selected as the starting point for bed selection 
using a random number generator. Thereafter, the occupant of every 
5th bed was included. When a bed was not occupied at the time of 
the interview, or the patient declined participation, the occupant of 
the bed immediately after and then immediately before the bed on 
the list was approached. Given that bed occupancy in wards varied, 
recruitment continued in each hospital until the subset sample size 
was reached.
Data collection
Data were collected using two instruments, both administered by 
a research assistant, done face to face and in sequence. A socio-
demographic survey was used to collect data on age, biological sex, 
race, relationship, dwelling type, employment status and education 
level. The World Health Organization (WHO)’s Alcohol, Smoking 
and Substance Involvement Screening Test (ASSIST)[20] was used to 
collect information on alcohol, tobacco and unregulated substance 
use.
ASSIST provides a calculation of the level of risk. Disaggregated by 
substance, risk levels are grouped into three categories, low, moderate 
and high, and attributed appropriate responses. People with low-risk 
scores were deemed not to warrant intervention. Those with moderate- 
or high-risk scores related to any substance were deemed to require 
intervention. The research assistant conducted a brief intervention 
using the WHO ‘feedback, responsibility, advice, menu of options, 
empathy and self-efficacy’ or FRAMES motivational interviewing 
approach[21] and offered referral to additional substance use services, 
introducing COSUP. Interested participants were provided with 
an information leaflet on COSUP. For participants whose risk 
scored moderate to high, the sociodemographic questionnaire 
had additional questions on previous help-seeking behaviour and 
previous experiences in hospitals relating to substance use. They also 
received introductory information about harm reduction from those 
conducting the interview and were invited to attend a COSUP site on 
discharge for more information.
Data were collected over a period of 4 weeks on electronic 
devices using Qualtrics, November 2017 version (Qualtrics, USA), a 
University of Pretoria cloud-based web survey platform.
Data analysis
Categorical variables are presented as frequency tables and 
numeri cal variables as descriptive measures. Associations between 
moderate- to high-risk use of tobacco and an unregulated substance 
and demographic and substance use characteristics were assessed 
using bivariate and multivariate logistic regression analysis. For the 
regression analysis, several variables were converted into binary 
variables. Converted variables included age (<38 years or ≥38 years, 
the median age), race (black African or other), education (completed 
at least high school or not), dwelling type (formal housing or other) 
and livelihood (employed or unemployed). Kalafong Hospital was 
used as the reference hospital for interhospital comparison. Odds 
ratios (ORs) were used to measure associations in the bivariate analysis 
and adjusted ORs (aORs) for multivariate analysis. The multivariate 
regression analysis included sociodemographic characteristics and 
alcohol use. Data were analysed using Stata v11 (StataCorp, USA).
Approval and consent
The study was approved by the University of Pretoria’s Faculty of 
Health Sciences Research Ethics Committee (ref. no. 369/2017) 
and the relevant hospitals. Respondents gave written informed 
consent before being interviewed. There was no reimbursement for 
participation.
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Results
In terms of sociodemographic characteristics and hospital entry 
pathways (Table 1), the median age of the respondents was 38 years 
(interquartile range (IQR) 28 - 50). Most were SA citizens (88%) and 
black African (79%), and lived in formal housing (82%). Over half 
(57%) were female, and over half (56%) had completed high school. 
Thirty-five percent of participants were cohabiting or married, and 
33% were formally employed. The median household income was 
ZAR1 400 per month (equivalent to USD100). Forty percent of 
participants were admitted for emergencies, and five people were 
admitted in relation to a consequence of their substance use.
Table 2 sets out the extent and kinds of moderate to high substance-
related risk by sex. One-third of the participants (32%, 129/401) had 
moderate to high scores for at least one of the substances included in 
the screening. Significantly more males (50%, 87/173) than females 
(18%, 42/228) met the moderate- to high-risk criteria and required 
some kind of intervention for their substance use.
Moderate to high ASSIST scores related especially to tobacco 
products (28%, 111/401), and risk due to tobacco use was notably 
higher among men than women (44% v. 15%). Twelve participants 
(3%) were assessed to be in need of additional treatment and were 
referred to appropriate services.
Alcohol was the second most common substance with moderate to 
high ASSIST scores (10%, 40/401), with a higher prevalence among 
males than females (19% v. 3%).
Seven per cent (28/401) of the participants had moderate to high 
cannabis risk scores, with a higher prevalence among males than 
females (15% v. 1%).
In terms of opioids, 11 respondents (3%) reported having ever used 
a non-regulated opioid (specifically heroin, known locally as nyaope, 
which is usually smoked with cannabis and may contain tobacco and/
or other bulking agents). Eight respondents said that they had used 
a non-regulated opioid during the previous 6 months, and 7 had 
injected it. One respondent had injected on a weekly basis during the 
3 months prior to the study. Nine respondents (2%), 8 of whom were 
male, had moderate to high ASSIST scores for opioids.
Moderate to high ASSIST scores were less frequent for other 
substances assessed as part of the ASSIST.
In terms of polysubstance use (Table 3), 32 respondents (8%) had 
moderate to high ASSIST scores for tobacco and an unregulated 
substance, mostly cannabis (n=24, 6%) and opioids (n=8, 2%), 
followed by sedatives and cocaine. Eleven (3%) had moderate to high 
scores for alcohol and cannabis, and 9 (2%) had moderate to high 
scores for tobacco, alcohol and cannabis.
Among respondents with moderate to high substance use scores, 
two-fifths (43%, 55/129) thought they needed professional assistance 
in view of their use of substances. Three in five (60%, 78/129) 
expressed interest in learning about a programme to help them 
reduce the health risks of their substance use without abstinence as a 
Table 1. Sociodemographic characteristics of participants  
and entry pathway from four teaching hospitals in Tshwane, 
South Africa, 2017 (N=401)
Hospital, n (%)
Kalafong 136 (33.9)
Mamelodi 70 (17.4)
SBAH 155 (38.7)
TDH 40 (10.0)
Sex, n (%)
Male 173 (43.1)
Female 228 (56.9)
Race, n (%)
Black African 317 (79.0)
Age (years), median (IQR) 38 (28 - 50)
Nationality, n (%)
SA citizen 351 (87.5)
Education, n (%)
Completed high school 225 (56.1)
Employed, n (%) 134 (33.4)
Relationship status, n (%)
Married or cohabiting 139 (34.7)
No. of children, median (IQR) 2 (1 - 3)
Dwelling, n (%)
Formal housing 328 (81.8)
 Average income (ZAR/month),  
median (IQR)
1 400 (0 - 4 000)
Entry path, n (%)
Emergency 161 (40.1)
Elective admission 51 (12.7)
Referral from other facility 189 (47.1)
 Admission related to substance use, 
n (%)
5 (1.2)
SBAH = Steve Biko Academic Hospital; TDH = Tshwane District Hospital;  
IQR = interquartile range.
Table 2. Overview of participants with moderate to high World Health Organization ASSIST scores* by hospital and sex in 
Tshwane, South Africa, 2017 (N=401)
Total (N=401), n (%) Mamelodi (N=70), n (%)  SBAH (N=155), n (%) TDH (N=40), n (%) Kalafong (N=136), n (%)
Substance
Male 
(N=173)
Female 
(N=228)
Male 
(N=32)
Female 
(N=38)
Male 
(N=74)
Female 
(N=81)
Male 
(N=17)
Female 
(N=23)
Male 
(N=50)
Female 
(N=86)
Any 
substance 
87 (50.3) 42 (18.4) 21 (65.6) 5 (13.2) 27 (36.5) 13 (16.0) 11 (64.7) 6 (26.1) 28 (56.0) 18 (20.9)
Tobacco 76 (43.9) 35 (15.4) 20 (62.5) 3 (7.9) 24 (32.4) 13 (16.0) 9 (52.9) 6 (26.1) 23 (46.0) 13 (15.1)
Alcohol 33 (19.1) 7 (3.1) 8 (25.0) 2 (5.3) 9 (12.2) 0 4 (23.6) 0 12 (24.0) 5 (5.8)
Cannabis 26 (15.0) 2 (0.9) 6 (18.8) 0 5 (6.8) 0 6 (35.3) 1 (4.3) 9 (18.0) 1 (1.2)
Opioids 8 (4.6) 1 (0.4) 0 0 2 (2.7) 0 4 (23.5) 1 (4.3) 2 (4.0) 0
Sedatives 3 (1.7) 6 (2.6) 0 1 (2.6) 3 (4.1) 0 0 0 0 5 (6.8)
Cocaine 3 (1.7) 1 (0.4) 1 (3.1) 0 1 (1.4) 0 1 (5.9) 1 (4.3) 0 0
ATS 0 2 (0.9) 0 1 (2.6) 0 1 (1.2) 0 0 0 0
ASSIST = Alcohol, Smoking and Substance Involvement Screening Test; SBAH = Steve Biko Academic Hospital; TDH = Tshwane District Hospital; ATS = amphetamine-type stimulant.
*Moderate substance use cut-off is an ASSIST score of ≥4, except for alcohol, which has a cut-off of 11.
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precondition. Most participants (84%, 108/129) said that they would 
potentially be willing to participate in a community-based substance 
use programme that used a harm reduction approach.
Thirteen participants (11/87 male and 2/42 female) with moderate 
to high substance use risk scores had sought professional help on at 
least one occasion, albeit not during the 12 months prior to the study. 
Help-seeking behaviour was highest among the few using cocaine 
(2/4) and opioids (3/9), and lowest among those with moderate- to 
high-risk use of alcohol or tobacco (3/40 and 11/111, respectively). 
Their main reasons for seeking professional help were personal 
(n=3), social pressure (n=3) and hospital admission (n=2). The 
most common services they received were inpatient rehabilitation 
services (n=5) and counselling (n=4). Eight participants reported 
having absconded from a health facility due to their substance use, 
2 of whom had high-risk opioid use scores. Detailed reasons for 
absconding were not collected.
The results of regression analysis are shown in Table 4. Bivariate 
analysis showed statistically significant (p<0.05) associations between 
moderate- to high-risk use of tobacco and an unregulated substance 
and being male (OR 5.3, 95% CI 2.3 - 12.6; p<0.001), being <38 years 
of age (OR 2.9, 95% CI 1.3 - 6.5; p=0.008), having moderate- to high-
risk alcohol use (OR 5.1, 95% CI 2.2 - 11.8; p<0.001) and being at 
Tshwane District Hospital compared with Kalafong Hospital (OR 2.8, 
95% CI 1.1 - 7.6; p=0.039).
Multivariate analysis showed that moderate to high scores for 
tobacco and an unregulated substance were positively associated 
with male sex (aOR 7.9, 95% CI 2.9 - 21.5; p<0.001), age <38 years 
(aOR 3.3, 95% CI 1.2 - 8.9; p=0.017), a moderate to high alcohol risk 
score (aOR 3.1, 95% CI 1.1 - 8.4; p=0.027) and admission to Tshwane 
District Hospital compared with Kalafong Hospital (aOR  3.6, 95% 
CI 1.1 - 12.2; p=0.038). Formal employment (aOR 0.2, 95% CI 0.1 - 
0.6; p=0.004) lowered the risk for a moderate to high score for 
tobacco and an unregulated substance. Being married or cohabiting 
was negatively associated with a moderate to high score for tobacco 
and an unregulated substance, but the association was not statistically 
significant (aOR 0.3, 95% CI 0.1 - 1.0; p=0.053).
Discussion
A third of the 401 patients admitted to four large public hospitals in 
Tshwane during the study period had moderate to high ASSIST scores 
for at least one substance.
The predominance of males with moderate to high scores 
for tobacco, alcohol and opioids aligns with the international 
literature. [16,22] In the SA setting, it may be that harmful use of 
substances is more common among men than among women. 
However, it is also likely that women who use substances harmfully 
are less visible and face a range of additional barriers to accessing 
services. Some additional barriers that women experience in 
seeking help for harmful substance use include less access to 
resources (including transport), limited family support, absence of 
childcare services, and fear that contact with the criminal justice 
system and social welfare services may jeopardise their custody of 
their children.[23-26] As such, given social expectations of women 
in their roles as caregivers[27] they are more likely to be affected by 
Table 3. Summary of moderate/high unregulated substance use in relation to moderate- to high-risk tobacco and alcohol use 
according to World Health Organization ASSIST scores* by hospital and sex in Tshwane, South Africa, 2017 (N=401)
Unregulated substance Tobacco, n (%) Alcohol, n (%) Tobacco and alcohol, n (%)
Any† 32 (8.0) 12 (3.0) 10 (2.5)
Cannabis 24 (6.0) 11 (2.7) 9 (2.2)
Opioids (heroin) 8 (2.0) 1 (0.2) 1 (0.2)
Sedatives 4 (1.0) 1 (0.2) 1 (0.2)
Cocaine 4 (1.0) 0 0
ATS 2 (0.5) 0 0
ASSIST = Alcohol, Smoking and Substance Involvement Screening Test; ATS = amphetamine-type stimulant.
*Moderate substance use cut-off is an ASSIST score of ≥4, except for alcohol, which has a cut-off of 11.
†This variable reflects participants who reported use of at least one unregulated substance (cannabis, opioids, sedatives, cocaine, ATS, hallucinogens, other non-specified unregulated substance) 
as well as use of tobacco and/or alcohol.
Table 4. Bivariate and multivariate associations with moderate to high World Health Organization ASSIST scores* for tobacco and 
a moderate to high score for an unregulated substance in Tshwane, South Africa, 2017
Variable OR p-value 95% CI aOR p-value 95% CI
Male sex 5.3 <0.001 2.2 - 12.6 7.9 <0.001 2.9 - 21.5
Age <38 years 2.9 0.008 1.3 - 6.5 3.3 0.017 1.2 - 9.0
Black African 1.2 0.750 0.5 - 2.9 0.8 0.644 0.2 - 2.5
Education (completed high school) 0.5 0.070 0.2 - 1.1 0.8 0.626 0.3 - 2.0
Dwelling (formal housing) 0.5 0.135 0.2 - 1.2 1.1 0.918 0.4 - 2.8
Employed 0.4 0.074 0.2 - 1.1 0.2 0.004 0.1 - 0.6
Married or cohabiting 0.4 0.055 0.2 - 1.0 0.3 0.053 0.1 - 1.0
Hospital
Kalafong - - -
Mamelodi 1.5 0.435 0.6 - 3.8 1.7 0.910 0.6 - 4.9
SBAH 0.4 0.079 0.1 - 1.1 0.4 0.136 0.1 - 1.4
TDH 2.8 0.039 1.1 - 7.6 3.6 0.038 1.1 - 12.2
Alcohol (moderate to high) 5.1 <0.001 2.2 - 11.8 3.1 0.027 1.1 - 8.4
ASSIST = Alcohol, Smoking and Substance Involvement Screening Test; SBAH = Steve Biko Academic Hospital; TDH = Tshwane District Hospital.
*Moderate substance use cut-off is an ASSIST score of ≥4, except for alcohol, which has a cut-off of 11.
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stigma and discrimination, exploitation by law enforcement and 
judgement from health workers.[28]
Similar to research findings elsewhere, the present study found an 
inverse relationship between moderate- to high-risk substance use 
and employment.[29] Being married or in a long-term relationship 
has been described as protective in many studies,[29-31] but was not 
statistically significant in this study. The association between younger 
age and increased moderate- to high-risk substance use has also been 
described elsewhere.[32,33] A number of studies show that substance 
use disorders resolve, often without intervention, at a predictable 
and constant rate[34-36] as people ‘mature out’[37] of risky substance 
use. As people secure permanent employment, enter into long-term 
relationships and take on the responsibilities of parenthood, these 
changing roles may displace the use of unregulated substances.[38] 
However, moderate- to high-risk use of alcohol and tobacco tends 
to follow a longer trajectory, which may in part be due to socially 
embedded acceptability as well as the slower trajectory of alcohol- 
and tobacco-related harms.[39-41]
The above findings suggest that there is congruence between SA 
and international data, and this could point to shared experiences of 
substance use and outcomes.
As expected, the most commonly used substances – alcohol 
and tobacco – are also the substances that carry the highest risk 
for harmful use, even though they are regulated.[10] We found that 
moderate- to high-risk tobacco use is associated with moderate- to 
high-risk use of alcohol and unregulated substances. In its own right 
and as an indicator for polysubstance use, the use of tobacco needs to 
be recognised as a significant risk factor among people admitted to 
hospital, and people with moderate- to high-risk smoking should be 
screened for the use of alcohol and unregulated substances.
Further, about one in 10 adult patients admitted to hospitals in 
Tshwane have moderate- or high-risk alcohol use patterns.
According to the ASSIST risk scores, almost half of the male 
participants in the present study and a sixth of females required 
some form of intervention for alcohol or tobacco use. Because of 
the strong association between harmful alcohol and tobacco use, 
and the increased health risk of their combination, there is a need 
for integrated brief interventions in healthcare settings, including 
hospitals.[42] Our findings point to the often-missed opportunity in 
healthcare settings to engage with issues of harmful substance use 
that have a direct bearing on patient treatment and health outcomes. 
The introduction of substance use screening and brief interventions 
as a standard of care could significantly reduce the negative impacts 
of these substances, and the associated costs.[43]
Cannabis was found to be the most common non-regulated 
substance used. While the health consequences of cannabis use 
are potentially less serious than those for the other non-regulated 
substances, there are social risks associated with its use, particularly 
the risk of exposure to the criminal justice system. Notwithstanding 
the 18 September 2018 Constitutional Court ruling that effectively 
decriminalised private use of cannabis and its production for private 
consumption (however, although the use of cannabis in a private 
setting is widely described as ‘legal’, this is not correct – cannabis is 
still considered a ‘scheduled substance’ in terms of the Drugs and 
Drug Trafficking Act No. 140 of 1992), there is a lot of discretion left 
in the hands of the police (South African Police Services Directive 
No. 1/1/4/1, September 2018) and quotas for arrest targets must still 
be met (senior South African Police Service members at Safer Western 
Cape dialogues, 13 and 14 November 2018, personal communication).
There were 11 patients with moderate- to high-risk heroin use 
(unregulated opioids) in the inpatient setting. It is widely reported 
that dependence on unregulated opioids places the individual at 
increased risk of morbidity and mortality, including from overdose. 
People who are dependent on opioids, particularly those who inject 
them, are at high risk of viral hepatitis, HIV and other blood-borne 
infections, a situation that may be compounded, if not driven, by the 
absence of sterile injecting equipment.[1]
Although in this study proportionately few respondents (3%) 
were found to have moderate- to high-risk use of heroin, over the 
past decade there has been an upward trend in heroin use among 
patients admitted to Gauteng substance use disorder treatment 
centres that report admissions data to the South African Community 
Epidemiology Network on Drug Use.[17] Of 3 414 individuals admitted 
between June and December 2017, 14% said that they used heroin as 
their primary drug, and it was the third most common substance 
used.[17] The numbers in the present study are therefore likely to 
be an under-representation of heroin-dependent people needing 
hospital admission.[44] Moreover, poor understanding of dependence 
and lack of provision of opioid agonists to address the clinical effect 
of opioid withdrawal, as well as limited professional understanding 
of pain management in these patients, may also contribute to 
the low numbers of people who use heroin being treated in these 
hospitals. Heroin-dependent patients often require higher doses of 
medications,[45] including short-acting opioids, to deal with increased 
pain sensitivity.[46] There are also fears that prescribing opioids may 
promote development of an opioid use disorder, although it has been 
shown that appropriate prescribing seldom leads to substance use 
disorders.[47]
The findings in the present study that levels and type of substance 
use involvement varied between hospitals may be idiosyncratic. They 
may also suggest local specificity, reflecting different substance use 
dynamics as well as the particularities of clinical services in the inner 
city, suburbs and townships.
Study limitations
The results of this study may underestimate the prevalence of 
substance use among patients admitted to hospitals owing to 
sensitivities around harmful substance use, particularly where 
unregulated substances are involved. To some extent these fears 
may have been countered by staff, who were trained to conduct 
interviews in a neutral and non-judgemental manner and to reassure 
participants of the steps taken to protect their information. However, 
these efforts would not impact on the number of people who leave 
hospital while waiting to be attended to or during their admissions 
or emergency unit consultations.[48] The study tools did not assess 
participants’ understanding of harm reduction as a concept. As a 
result, responses related to their willingness to use harm reduction 
services may not have been measured accurately.
Conclusions and recommendations
The study highlights that a significant proportion of hospital patients 
use regulated and unregulated substances, often in a way that puts 
them at moderate to high risk. We identified a relationship between 
moderate- to high-risk use of tobacco and moderate- to high-risk use 
of unregulated substances. The causal relationship between potentially 
high-risk tobacco use and unregulated substance use cannot be 
assessed in a cross-sectional survey, but the study has identified 
substance use as an important area of healthcare in hospitals, 
particularly among young men facing socioeconomic hardship.
Additional assessment of the feasibility of using the WHO ASSIST, 
particularly the brief intervention linked to screening, is needed to 
further inform its role in hospital settings.
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There is a need for patients who are dependent on opioids or other 
substances to receive adjunctive interventions for the duration 
of their in-hospital treatment. As in other settings, and in line 
with international guidelines, opioid substitution therapy (OST) in 
hospitals should use adequate doses. On leaving hospital, patients 
should be offered the best available primary healthcare, including 
access to OST. For facilities in the City of Tshwane, for example, OST 
is increasingly available through COSUP.[49]
As per the Batho Pele principles (constitutionally based principles 
outlining the way in which public services should be provided: they 
are consultation, service standards, access, courtesy, information, 
openness and transparency, redress and value for money), all 
patients should receive non-judgemental services. Hospital staff 
should be adequately trained around the risks of regulated and 
unregulated substances and on brief interventions and referral. 
An assessment of hospital staff knowledge, attitudes and practices 
around substance use would be an important first step towards 
in-service and undergraduate health worker training.
From the perspective of patients, approaches that reduce the 
potential harms of substance use without necessarily requiring the 
individual to abstain are likely to elicit better responses to treatment, 
as will self-management, and should be evaluated further. Additional 
research to assess levels of substance use among hospital patients in 
emergency, casualty, maternity and outpatient units is also needed.
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